Evidence map›Paper›PMID 42073590›Full record

ArticleCancers2026

Comparing Response Evaluation Methods for PRRT in Neuroendocrine Tumors: Insights from an Exploratory Study.

Priscilla Guglielmo, Carlo Carnaghi, Alexia Francesca Bertuzzi, Alice Laffi, Sara Damiani, Ugo Carlo Riva, Michela Olivieri, Manuela Marenco, Laura Evangelista

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Priscilla GuglielmoDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
Carlo CarnaghiMedical Oncology Unit, Humanitas Istituto Clinico Catanese, Misterbianco, 95045 Catania, Italy.
Alexia Francesca BertuzziMedical Oncology and Haematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Alice LaffiDivision of Medical Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.ORCID 0000-0001-7458-3366
Sara DamianiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.ORCID 0009-0004-2622-8123
Ugo Carlo RivaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
Michela OlivieriMedical Physics Unit, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.ORCID 0009-0000-2344-3865
Manuela MarencoNuclear Medicine Unit, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Laura EvangelistaNuclear Medicine Unit, Humanitas Gavazzeni, 24125 Bergamo, Italy.ORCID 0000-0002-5955-9488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NETneuroendocrine tumorsPRRTradioligand therapyresponse evaluation

Identifiers

PMID42073590
PMCPMC13114807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.